CXCR4 (RR: 5.440; P = 0.023) and UICC T3 stage (P = 0.010) were the independent risk factors that most strongly associated with reduced disease-free survival in patients with bone metastasis. This evidence concerns the gene CXCR4 and bone metastasis.